The English website of the "Alessandra Graziottin Foundation" boosted on line

Back to Scientific Updates

29/06/2009

Premature menopause and sexual outcomes

Graziottin A.
Premature menopause and sexual outcomes
European Endocrine Diseases 2007, Issue 1, p. 87-90

The prolonged survival of children, adolescents and young women successfully treated for cancer increases the number of women facing premature menopause (PM). PM accelerates general health and sexual ageing, unless appropriate HT – when non-contraindicated – is initiated and maintained over time. Reports of FSD increase after PM. Women with PM are at higher risk of distressing sexual disorders. RCTs indicate that HT with oestrogen and testosterone may have a positive effect on all domains of sexual function, especially after surgical PM.

By courtesy of Touch Briefings (all copyright and permissions to reprint retained)

top

Available documents:
Full text of the article

19/10/2009 - Hormonal therapy after menopause

07/09/2009 - Premature ovarian failure: frequency and risk factors among women attending a network of Menopause Clinics in Italy

22/06/2009 - Menopausal status, hormone replacement therapy use and risk of self-reported physician-diagnosed osteoarthritis in women attending menopause clinics in Italy

15/06/2009 - Effect of premature menopause on sexuality

19/01/2009 - Premature menopause: the challenge of accelerated sexual aging

Keywords:
Breast Cancer - Gynaecologic Cancer - Chemotherapy - Female Dyspareunia - Sexual Pain Disorders - Female Sexual Disorders - Infertility - Iatrogenic Menopause - Sexual Hormones - Oophorectomy/Ovariectomy - Radiotherapy - Hormone Replacement Therapy (HRT)

FAIR USE: The content of this paper can be downloaded, printed and read for strictly personal and non-profit use. Any citation for didactic and/or scientific purpose must quote the title of the document, the name of the author(s), the data of the book or journal, and the URL of the site (www.fondazionegraziottin.org).

WARNING: Every therapy must be discussed, tailored, prescribed and monitored by the M.D. personally consulted. Every information presented in this website can not surrogate the personal relationship with the caring physician nor be utilized without specific medical advice.

Back to Scientific Updates

C.F./P.IVA: 060 829 20 965

Terms and conditions - Privacy policy - Credits